Kayhan Tarim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kayhan Tarim has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
- Ersin Köseoğlu
Department of Urology, School of Medicine Koc University Istanbul Turkey
6 shared publications - Tarik Esen
School of Medicine, Koc University, Istanbul, Turkey
5 shared publications - Yakup Kordan
KOÇ ÜNİVERSİTESİ, TIP FAKÜLTESİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ, ÜROLOJİ ANABİLİM DALI
5 shared publications - Murat Can Kiremit
Department of Urology, School of Medicine, Koc University, Istanbul, Turkey
4 shared publications - Abdullah Erdem Canda
KOÇ ÜNİVERSİTESİ, TIP FAKÜLTESİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ, ÜROLOJİ ANABİLİM DALI
3 shared publications Mevlana Derya Balbay
3 shared publications
Latest Publications
- 1 December 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 44 (1) , 8
Optimizing prostate biopsy: the role of targeted, regional, and systematic approaches
- 1 December 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 44 (1) , 8
Optimizing prostate biopsy: the role of targeted, regional, and systematic approaches
- 30 September 2025
- Published by Endouroloji Dernegi in Endouroloji Bulteni
- Vol. 17 (3) , 111-118
Factors Affecting Forgotten Ureteral Stents
Objective: Ureteral double-J (DJ) stents are frequently used in urology. Overdue or forgotten DJ stents are associated with many complications. This study will examine the factors affecting the stent forgetting period of patients with forgotten DJ stents. Materials and Methods: It was reviewed by Ağrı İbrahim Çeçen University Scientific Research Ethics Committee and approved with the decision numbered 108 dated 27.03.2025. Data from 12 patients with DJ stent indwelling longer than 6 months between January 2017 and December 2024 at Ağrı Training and Research Hospital, a rural tertiary center in Türkiye, were examined. Two groups were formed according to the median stent indwelling time: short-term (group 1) and long-term (group 2). The patient’s age, gender, DJ stent placement indication, additional endourological procedure need and duration, restenting rates, and distances to the hospital were compared. Results: There was no difference between the two groups regarding gender, indication for stent placement, additional endourological procedures, and restenting rate after additional endourological procedures. The mean age was 43.5 years (SD: 11) in group 1 and 61.3 years (SD : 9.5) in group 2 (p: 0.012). Median additional endourological procedures’ duration was 37.5 minutes (IQR:27.5-40) in group 1 and 67.5 minutes (IQR: 52.5-87.5) in group 2 (p = 0.005). Median distance to the hospital was 38.5 kilometers (IQR: 19.25-77.75) in group 1 and 85.5 kilometers (IQR: 75.75-91.5) in group 2 (p = 0.037). Conclusion: Our study concluded that patients whose DJ stents were forgotten for longer were older and resided in a center farther from the hospital. It would be beneficial to be careful, especially in this patient group.
- 30 September 2025
- Published by Endouroloji Dernegi in Endouroloji Bulteni
- Vol. 17 (3) , 111-118
Factors Affecting Forgotten Ureteral Stents
Objective: Ureteral double-J (DJ) stents are frequently used in urology. Overdue or forgotten DJ stents are associated with many complications. This study will examine the factors affecting the stent forgetting period of patients with forgotten DJ stents. Materials and Methods: It was reviewed by Ağrı İbrahim Çeçen University Scientific Research Ethics Committee and approved with the decision numbered 108 dated 27.03.2025. Data from 12 patients with DJ stent indwelling longer than 6 months between January 2017 and December 2024 at Ağrı Training and Research Hospital, a rural tertiary center in Türkiye, were examined. Two groups were formed according to the median stent indwelling time: short-term (group 1) and long-term (group 2). The patient’s age, gender, DJ stent placement indication, additional endourological procedure need and duration, restenting rates, and distances to the hospital were compared. Results: There was no difference between the two groups regarding gender, indication for stent placement, additional endourological procedures, and restenting rate after additional endourological procedures. The mean age was 43.5 years (SD: 11) in group 1 and 61.3 years (SD : 9.5) in group 2 (p: 0.012). Median additional endourological procedures’ duration was 37.5 minutes (IQR:27.5-40) in group 1 and 67.5 minutes (IQR: 52.5-87.5) in group 2 (p = 0.005). Median distance to the hospital was 38.5 kilometers (IQR: 19.25-77.75) in group 1 and 85.5 kilometers (IQR: 75.75-91.5) in group 2 (p = 0.037). Conclusion: Our study concluded that patients whose DJ stents were forgotten for longer were older and resided in a center farther from the hospital. It would be beneficial to be careful, especially in this patient group.
- 16 September 2025
- Published by Academician Publishing
Open Accessİşlevsel Üroloji ve Kadın Ürolojisi
- Open Access
- 1 January 2024
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 50 (5) , 275-280
Revisiting Skull Metastases of Prostate Cancer at Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography Era: PSMA Uptake Characteristics and Oncological Outcomes
Objective: We aimed to evaluate prostate-specific membrane antigen (PSMA) uptake characteristics and the oncological outcomes in patients with skull metastases. Methods: The records of 345 serial PSMA positron emission tomography (PET)/computed tomography (CT) scans of 96 patients with metastatic prostate cancer (PCa) were evaluated retrospectively. Skull bone metastasis was detected in 18 patients (18/96, 18.7%), with a mean age of 72.4 Å} 9.1 years, and in 40 PSMA PET/CT scans (40/345, 11.6%). Involved skull bones, PSMA uptake characteristics, and CT counterparts of metastatic lesions were centrally reviewed. Prostate specific antigen (PSA) levels at the time of skull metastasis detection and PSMA-detected other metastatic lesions were recorded. Results: All patients with a skull metastasis showed multiple other metastatic bon lesions, and 6 (33.3%) had visceral metastasis. Seven (38.9%) patients had solitary skull lesions, whereas 11 (61.1%) had multiple skull metastases. Twenty-two out of 37 (59.5%) metastatic lesions had no CT counterpart. The median SUVmax was significantly higher in metastatic lesions with a CT counterpart (median 9.09 vs. 4.63, P = .018). At a median follow-up of 23.4 mo (interquartile range [IQR] 8.7-34.1) after detection of skull metastasis, 5 out of 11 (45.5%) hormone-sensitive and all castration-resistant patients died of PCa. The median survival of patients with castration-resistant disease was 9.92 months. Conclusion: The majority of PSMA-detected skull metastases did not show a CT counterpart, which may explain why skull metastases were rarely detected before the PSMA PET-era. In high-volume metastatic prostatic cancer cases, 68Ga-PSMA PET/CT imaging field including the vertex, may enhance the accuracy in detecting tumor extent and metabolic tumor volume. Cite this article as: Esen B, Falay O, Tarim K, et al. Revisiting skull metastases of prostate cancer at prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography era: PSMA uptake characteristics and oncological outcomes. Urol Res Pract. 2024;50(5):275-280.
- 1 January 2024
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 50 (5) , 275-280
Open AccessRevisiting Skull Metastases of Prostate Cancer at Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography Era: PSMA Uptake Characteristics and Oncological Outcomes
Objective: We aimed to evaluate prostate-specific membrane antigen (PSMA) uptake characteristics and the oncological outcomes in patients with skull metastases. Methods: The records of 345 serial PSMA positron emission tomography (PET)/computed tomography (CT) scans of 96 patients with metastatic prostate cancer (PCa) were evaluated retrospectively. Skull bone metastasis was detected in 18 patients (18/96, 18.7%), with a mean age of 72.4 Å} 9.1 years, and in 40 PSMA PET/CT scans (40/345, 11.6%). Involved skull bones, PSMA uptake characteristics, and CT counterparts of metastatic lesions were centrally reviewed. Prostate specific antigen (PSA) levels at the time of skull metastasis detection and PSMA-detected other metastatic lesions were recorded. Results: All patients with a skull metastasis showed multiple other metastatic bon lesions, and 6 (33.3%) had visceral metastasis. Seven (38.9%) patients had solitary skull lesions, whereas 11 (61.1%) had multiple skull metastases. Twenty-two out of 37 (59.5%) metastatic lesions had no CT counterpart. The median SUVmax was significantly higher in metastatic lesions with a CT counterpart (median 9.09 vs. 4.63, P = .018). At a median follow-up of 23.4 mo (interquartile range [IQR] 8.7-34.1) after detection of skull metastasis, 5 out of 11 (45.5%) hormone-sensitive and all castration-resistant patients died of PCa. The median survival of patients with castration-resistant disease was 9.92 months. Conclusion: The majority of PSMA-detected skull metastases did not show a CT counterpart, which may explain why skull metastases were rarely detected before the PSMA PET-era. In high-volume metastatic prostatic cancer cases, 68Ga-PSMA PET/CT imaging field including the vertex, may enhance the accuracy in detecting tumor extent and metabolic tumor volume. Cite this article as: Esen B, Falay O, Tarim K, et al. Revisiting skull metastases of prostate cancer at prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography era: PSMA uptake characteristics and oncological outcomes. Urol Res Pract. 2024;50(5):275-280.
- Open Access
- 1 January 2023
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 53 (1) , 183-192
PSA change after antibiotic treatment should not affect decision-making on performing a prostate biopsy
Background/aim: To investigate the effect of antibiotic treatment on PSA when deciding on prostate biopsy. Materials and methods: A total of 206 patients with an elevated PSA level (2.5-30) were included. Mp-MRI could be done on 129 patients. Patients were given ciprofloxacin (500 mg, b.i.d. p.o.) for 4 weeks and PSA measurements were repeated. Systematic prostate biopsy was performed regardless of PSA changes on all patients. Additionally, cognitive biopsies were performed from PI-RADs III, IV, and V lesions. Results: Prostate cancer was detected in 36.4% of patients. 53.3% had Gleason score of 3+3, 46.7% had Gleason score ≥ 3+4. PSA values decreased in 56.3% and in 43.7% and remained the same or increased but cancer detection rates were not different: 34.5% vs. 38.9%, respectively (p = 0.514). PSA change in whole group was significant (6.38 ng/mL vs. 5.95 ng/mL, respectively (p = 0.01). No significant PSA decrease was observed in cancer patients (7.1 ng/mL vs. 7.05 ng/mL, p = 0.09), whereas PSA decrease was significant in patients with benign pathology (6.1 ng/mL vs. 5.5 ng/mL, p = 0.01). In patients with PI-RADs IV-V lesions, adenocarcinoma was present in 33.9% and 30.4% with or without PSA decrease, respectively (p = 0.209). Clinically significant cancer was higher in patients with after antibiotherapy PSA values >4 ng/mL regardless of PI-RADs grouping (p = 0.08). Addition of any PSA value to PI-RADs grouping did not have any significant effect on the detection of cancer. Conclusion: PSA change after antibiotic treatment has no effect in detecting cancer and should not delay performing a biopsy
- 1 January 2023
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 53 (1) , 183-192
Open AccessPSA change after antibiotic treatment should not affect decision-making on performing a prostate biopsy
Background/aim: To investigate the effect of antibiotic treatment on PSA when deciding on prostate biopsy. Materials and methods: A total of 206 patients with an elevated PSA level (2.5-30) were included. Mp-MRI could be done on 129 patients. Patients were given ciprofloxacin (500 mg, b.i.d. p.o.) for 4 weeks and PSA measurements were repeated. Systematic prostate biopsy was performed regardless of PSA changes on all patients. Additionally, cognitive biopsies were performed from PI-RADs III, IV, and V lesions. Results: Prostate cancer was detected in 36.4% of patients. 53.3% had Gleason score of 3+3, 46.7% had Gleason score ≥ 3+4. PSA values decreased in 56.3% and in 43.7% and remained the same or increased but cancer detection rates were not different: 34.5% vs. 38.9%, respectively (p = 0.514). PSA change in whole group was significant (6.38 ng/mL vs. 5.95 ng/mL, respectively (p = 0.01). No significant PSA decrease was observed in cancer patients (7.1 ng/mL vs. 7.05 ng/mL, p = 0.09), whereas PSA decrease was significant in patients with benign pathology (6.1 ng/mL vs. 5.5 ng/mL, p = 0.01). In patients with PI-RADs IV-V lesions, adenocarcinoma was present in 33.9% and 30.4% with or without PSA decrease, respectively (p = 0.209). Clinically significant cancer was higher in patients with after antibiotherapy PSA values >4 ng/mL regardless of PI-RADs grouping (p = 0.08). Addition of any PSA value to PI-RADs grouping did not have any significant effect on the detection of cancer. Conclusion: PSA change after antibiotic treatment has no effect in detecting cancer and should not delay performing a biopsy
- 1 June 2021
- Published by Elsevier in European Urology
- Vol. 79, S1172-S1173
Preoperative prediction of lymph node invasion in prostate cancer: Ga-68 PSMA PET or nomograms?
- 1 June 2021
- Published by Elsevier in European Urology
- Vol. 79, S1172-S1173
Preoperative prediction of lymph node invasion in prostate cancer: Ga-68 PSMA PET or nomograms?
- Open Access
- 1 April 2021
- Published by Taylor & Francis in Robotic Surgery: Research and Reviews
- Vol. ume 8, 1-7
Genitalia Preserving Robotic Radical Cystectomy with Intracorporeal Studer Pouch Formation in the Female: Experience in 5 Cases
We present operative, postoperative, oncologic and functional outcomes of genital tract sparing robot-assisted laparoscopic radical cystectomy, bilateral extended pelvic lymph node (LN) dissection and intracorporeal Studer pouch construction on five female patients with bladder cancer. One of the cases had concomitant nephroureterectomy performed due to a non-functioning kidney. Median patient age, mean operation time, median estimated blood loss and mean duration of hospital stay were 59 (39– 78), 462 ± 25, 400 (50– 970), 8.8 ± 2.5, respectively. Pathologic stages were pTis (n=1), pT1 (n=1), pT3 (n=1), pT4a (n=1) and pT4b (n=1). Mean LN yield was 32.4 ± 8.9. Positive surgical margins were detected in 2 patients with pT4 diseases. Only minor complications developed that were resolved with medical treatment. Two patients had no, 1 patient had mild, and 2 patients had moderate daytime incontinence. One patient had good, 3 patients had fair, and 1 had poor night-time incontinence. This complex robotic surgery can be performed safely with acceptable short-term surgical, oncological and functional outcomes.
- 1 April 2021
- Published by Taylor & Francis in Robotic Surgery: Research and Reviews
- Vol. ume 8, 1-7
Open AccessGenitalia Preserving Robotic Radical Cystectomy with Intracorporeal Studer Pouch Formation in the Female: Experience in 5 Cases
We present operative, postoperative, oncologic and functional outcomes of genital tract sparing robot-assisted laparoscopic radical cystectomy, bilateral extended pelvic lymph node (LN) dissection and intracorporeal Studer pouch construction on five female patients with bladder cancer. One of the cases had concomitant nephroureterectomy performed due to a non-functioning kidney. Median patient age, mean operation time, median estimated blood loss and mean duration of hospital stay were 59 (39– 78), 462 ± 25, 400 (50– 970), 8.8 ± 2.5, respectively. Pathologic stages were pTis (n=1), pT1 (n=1), pT3 (n=1), pT4a (n=1) and pT4b (n=1). Mean LN yield was 32.4 ± 8.9. Positive surgical margins were detected in 2 patients with pT4 diseases. Only minor complications developed that were resolved with medical treatment. Two patients had no, 1 patient had mild, and 2 patients had moderate daytime incontinence. One patient had good, 3 patients had fair, and 1 had poor night-time incontinence. This complex robotic surgery can be performed safely with acceptable short-term surgical, oncological and functional outcomes.
- 13 October 2020
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 15 (5) , 671-677
Feasibility, safety and efficacy of argon beam coagulation in robot-assisted partial nephrectomy for solid renal masses ≤ 7 cm in size
One of the most important steps of the partial nephrectomy (PN) is hemostatic control of tumor bed which also effects the warm ischemia time (WIT). Argon beam coagulation (ABC) for decades is a well-known method for surface controls during major open surgical sites. This study aimed to compare peri- and postoperative relevant parameters in patients with ABC or internal renorrhaphy (IR) during robot-assisted partial nephrectomy (RAPN). One hundred seventy patients with ≤ 7 cm tumors, who underwent RAPN at our institutions, were included in this retrospective study. Tumor bed was controlled by either IR or by ABC after closing isolated overt collecting system defects. No additional IR was performed in patients with ABC. Estimated blood loss (EBL), WIT, estimated glomerular filtration rate (eGFR) change, on- vs. off-clamp procedure as well as Clavien-Dindo > 2 complications in both groups were compared. Eighty-seven (51.1%) patients had ABC and 83 (48.9%) had IR as their tumor bed control method. Tumor size, side and RENAL nephrometry score in both groups were similar. Mean warm ischemia time (WIT) was 20.8 min in ABC group and 23.8 min in IR group (p = 0.03). In 4–7 cm tumors, WIT was 19.9 min in ABC group while 26.6 min in IR group (p = 0.026). eGFR change from baseline and EBL favored ABC in entire cohort as well as in 4–7 cm tumors with statistical significance. There were more off-clamp procedures with ABC in ≤ 4 cm tumors. No ABC specific complications were observed. Within 2 years of follow-up, no patient developed recurrences. The control of the tumor base with ABC during RAPN shortens the warm ischemia times significantly compared to IR. Besides, ABC had better EBL and GFR changes outcomes. With close monitoring of intra-abdominal pressure and frequent venting, disturbing complications of ABC could completely be avoided. ABC was found to be feasible, safe and effective during RAPN.
- 13 October 2020
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 15 (5) , 671-677
Feasibility, safety and efficacy of argon beam coagulation in robot-assisted partial nephrectomy for solid renal masses ≤ 7 cm in size
One of the most important steps of the partial nephrectomy (PN) is hemostatic control of tumor bed which also effects the warm ischemia time (WIT). Argon beam coagulation (ABC) for decades is a well-known method for surface controls during major open surgical sites. This study aimed to compare peri- and postoperative relevant parameters in patients with ABC or internal renorrhaphy (IR) during robot-assisted partial nephrectomy (RAPN). One hundred seventy patients with ≤ 7 cm tumors, who underwent RAPN at our institutions, were included in this retrospective study. Tumor bed was controlled by either IR or by ABC after closing isolated overt collecting system defects. No additional IR was performed in patients with ABC. Estimated blood loss (EBL), WIT, estimated glomerular filtration rate (eGFR) change, on- vs. off-clamp procedure as well as Clavien-Dindo > 2 complications in both groups were compared. Eighty-seven (51.1%) patients had ABC and 83 (48.9%) had IR as their tumor bed control method. Tumor size, side and RENAL nephrometry score in both groups were similar. Mean warm ischemia time (WIT) was 20.8 min in ABC group and 23.8 min in IR group (p = 0.03). In 4–7 cm tumors, WIT was 19.9 min in ABC group while 26.6 min in IR group (p = 0.026). eGFR change from baseline and EBL favored ABC in entire cohort as well as in 4–7 cm tumors with statistical significance. There were more off-clamp procedures with ABC in ≤ 4 cm tumors. No ABC specific complications were observed. Within 2 years of follow-up, no patient developed recurrences. The control of the tumor base with ABC during RAPN shortens the warm ischemia times significantly compared to IR. Besides, ABC had better EBL and GFR changes outcomes. With close monitoring of intra-abdominal pressure and frequent venting, disturbing complications of ABC could completely be avoided. ABC was found to be feasible, safe and effective during RAPN.
- 1 September 2019
- Published by Elsevier in European Urology Supplements
- Vol. 18 (6) , e2719
Prostatic ductal adenocarcinoma mimicking bladder cancer successfully treated with robotic radical prostatecectomy
- 1 September 2019
- Published by Elsevier in European Urology Supplements
- Vol. 18 (6) , e2719
Prostatic ductal adenocarcinoma mimicking bladder cancer successfully treated with robotic radical prostatecectomy